Search

everythinglearnresearchcommunity

for

Search:↓

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Children with systemic lupus erythematosus have different skin symptoms than adults.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

New treatments and understanding of skin lupus are emerging in 2024.

The patient has Chronic Cutaneous Lupus, a skin condition causing plaques and hair loss.

SLE and DM can coexist but are rare and need careful evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.